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Background: Although effectiveness of web-based interventions on lifestyle changes are recognized, the potential
of such programs on metabolic syndrome has not been explored. We describe the protocol of a randomized
controlled trial that aims to determine the feasibility, acceptability, usability, and effectiveness of interactive
technology on lifestyle intervention in a population with metabolic syndrome.
Methods/design: This is a two-arm randomized controlled trial. The study includes 160 participants (n = 80 per
arm) who will be recruited via online registration on the study website. The inclusion criteria are that they should
have metabolic syndrome and have access to the Internet. All participants will receive information on dietary intake
and physical activity through the study website. The intervention group will receive additional resources via the
study website including interactive Healthy Heart Profile and calorie restricted diet tailored to the participants. The
primary outcomes are feasibility, acceptability, usability, and the change in metabolic syndrome components. The
secondary outcomes are comparing quality of life, physical activity and food intake among the study arms. The
participants will be followed up to 6 months with data collection scheduled at baseline, 3 and 6 months.
Discussion: There is a need for developing and evaluating web-based interventions that target people with high
risk for cardiovascular diseases. This study will therefore make an important contribution to this novel field of
research and practice.
Trial registration: IRCT201111198132N1Background
Cardiovascular diseases (CVD) are the leading cause of
mortality and morbidity worldwide and a growing health
problem among developing nations [1,2]. It is argued that
metabolic syndrome is the most responsible risk factor for
developing the disease [3-6]. The National Cholesterol
Education Program Adult Treatment Panel (ATP) III
defined metabolic syndrome as the presence of three
or more of the following conditions: triglyceride level of
at least 150 mg/dl, HDL level less than 40 mg/dl in men
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reproduction in any medium, provided the orpressure 130/85 mm Hg or higher, fasting blood glucose
level 110 mg/dl or higher and waist circumference greater
than 102 cm in men and greater than 88 cm in women
[7]. Metabolic syndrome is affecting about 20% of adult
population without known diabetes and cardiovascular
diseases and is associated with increasing cardiovascular
morbidity and mortality [8,9]. Ischemic heart disease
was the leading cause of Disability-Adjusted Life Years
(DALYs) worldwide in 2010 [10].
Recent evidence indicates that individuals with meta-
bolic syndrome are approximately twice more likely to
develop cardiovascular disease and between 3.5 and 5
times more likely to develop type 2 diabetes [11]. The
prevalence of metabolic syndrome in Iran is very high.
The Tehran Lipid and Glucose study (TLGS) reported
that 42% of women and 24% of men were suffering
from metabolic syndrome. Metabolic syndrome has beenral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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duced high-density lipoprotein cholesterol (HDL), hyper-
tension, and elevated fasting blood glucose concentration
[12-14]. Increased cardiovascular mortality and metabolic
syndrome morbidity in developing countries is largely due
to the changes in lifestyle including changes in dietary
habits and lack of exercise [15-17]. Therefore effective and
affordable strategies to control the syndrome would bene-
fit the at risk population.
In the past there have been several different strategies
to fight metabolic syndrome. Although traditional life-
style interventions such as face-to-face diet and exercise
programs have succeeded in treating the metabolic syn-
drome [18,19], clinical practice and research have shown
significant difficulties with regard to availability, cost,
treatment adherence and long-term efficacy of these
procedures [20]. Indeed issues such as time and travel
demands typically were identified as problems with
traditional programs [21]. However, the new communica-
tion technologies provided alternatives that are becoming
very popular. For instance the Internet penetration rapidly
is growing and its use in medicine and health care are ever
increasing. In particular web-based interventions has
attracted a considerable attention as an approach in
medical discipline.
A web-based intervention provides easily access to
evidence-based content in every time and makes it feas-
ible to increase tremendously the number of people
reached to information [20,22,23]. According to Barak
et al. a web-based intervention is: ‘a primarily self-guided
intervention program that is executed by means of a pre-
scriptive online program operated through a website and
used by consumers seeking health- and mental-health
related assistance’ [24]. The effectiveness of web-based
interventions has been demonstrated for numerous health
behaviors and chronic conditions. Review studies of web-
based interventions reported positive results for smoking
cessations [25-31], substance abuse [32], alcohol con-
sumption [28,33-39], weight management [20,40-46],
diabetes care [47,48], depression, anxiety and stress
[49-55], physical activity and nutrition [56-61] and
chronic conditions [62,63]. However, the effectiveness
of these online applications is limited by high attrition
rates and the fact that only few users visit a health inter-
vention website more than once [64,65]. In addition, it
is argued although there is some evidence for the effective-
ness of web-based interventions for improving healthy be-
haviors, it is clear that maintaining improvements remain
a challenging issue [66].
There is evidence that among the web-based interven-
tions for lifestyle changes those that benefit from inter-
active technology are more effective than those that
provide one-way communications [66]. Interactive web-
based technology is a two-way communication by whichusing the Internet, people could interact with provider.
Interactive web-based technologies have several advan-
tages. Access to credible information is quick and easy
to read updated information [66]. Lower cost, better
interaction, less time between screening and feedback
are other returns of interactive web-based interventions
[59,67]. Interactive web-based programs can offer tailored
information and messages to participants to personalize
their experience and apply interventions in the privacy of
their home and at the convenient time [23]. In fact by
using interactive web-based technology one could design
web-based interventions tailored to the need of target
population. Therefore with the growth of new and exciting
interactive technologies, opportunities to use this novel
applicable approach is recommended to design easy to
use, engaging, continual self-monitoring program for
metabolic syndrome.
Internet penetration in Iran is 53.3% and 46.7% of
people are using the Internet [68]. A recent study indi-
cated that 32.7% of people living in Tehran (the capital)
have used Internet at the past 12 months [69]. As any
other communities the use of the Internet in Iran is rap-
idly increasing. However, in spite of that increase, we are
not aware of any evaluation of web-based health programs
conducted in Tehran, Iran.
Aim
The aim of this randomized controlled trial (RCT) is to
determine the feasibility, acceptability, usability, and effect-
iveness of an interactive web-based lifestyle intervention
focusing on dietary and physical activity for reducing
metabolic syndrome indicators. It was hypothesized that
developing and launching an interactive web-based edu-
cational program would be feasible, acceptable and will
be used by target audiences, and that using interactive
web-based educational program will produce a change
in lifestyle behaviors and this consequently will lead to
reduction in metabolic syndrome.
Methods
Trial design
This study is an interactive web-based randomized trial
(using pre and post-intervention assessments). Partici-
pants in this parallel study randomly will be assigned to
one of two conditions: the intervention group and the
waiting list group (the control group). Participants will
be assessed at three points in time: at baseline, three and
six months follow-up. Study procedure from enrollment
through follow up data collection and analysis are
depicted in Figure 1.
Study procedure
An interactive web page namely Healthy Heart Education
(http://www.Heartresearch.ir) is designed in order to
Figure 1 ‘Red Ruby’: the trial flow chart.
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vascular diseases and attract the attention of users for
metabolic syndrome [Figure 2]. It is a free website pro-
viding information and advice about reducing heart dis-
eases. This public website presents general information
about hypertension, metabolic syndrome, diabetes,
obesity and central obesity, nutrition for healthy heart
and cardiovascular diseases (types, symptoms, preven-
tion). The general educational materials are available in
HTML and PDF formats. There is a registration page
that invites people to take part in a study named the
‘Red Ruby’. The registration page includes recording of
information on name, gender, age, waist circumference,
weight, e-mail and address. The homepage also shows
how to measure waist circumference.Recruitment
The study will be advertised by posters in virtual and
non-virtual environments by announcing the web site
address and indicating that people could visit the site for
further information. Then those who visit the site will
be invited to participate in the study by registering in
the site. Accordingly the website’s database will be
reviewed by a trained research assistance in order to iden-
tify registrant aged 20 and over living in Tehran (the study
setting). Then, those who meet the study criteria will be
contacted by the main investigator (LJ). Finally identified
eligible participants who interested in pursuing the study,
will ask to schedule for a free clinic visit and clinical
measurements by a trained nursing staff at Tehran
Heart Center.
Figure 2 A snapshot of the website.
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Participants are individuals that should have metabolic
syndrome aged 20 years and above living in Tehran reg-
istered on the study website.
Inclusion criteria
a) Waist circumference ≥ 90 (cut-off for metabolic syn-
drome in Iran for both gender [70-72]), b) Blood pres-
sure ≥ 130/85, c) Access to Internet, d) Having simple
skills to work with Internet
Exclusion criteria
a) Having history of cardiovascular diseases, b) Diabetics,
c) Having cancer, d) Patients with renal diseases, e) Being
pregnant, f ) Taking medication for hypertension, g) Taking
medication for dislipidemia, and h) Having incomplete
registration form
Randomization
Randomization will be carried out after baseline measure-
ments. Participants will be randomly assigned to the trial
arms. Randomization sequence will created manually by
a biostatistician using Excel software [Command in the
Excel for random block sizes column: =rand()] [73] to as-
sign participants to the study arms using a 1:1 allocation
ratio with block size of 4. The allocation sequence will
conceal from the investigators in sequentially numbered,
opaque, sealed and stapled envelopes.
Intervention
Both intervention and control arms will be encouraged
to engage in making healthy changes to their physical
activity and nutrition behaviors in order to treat meta-
bolic syndrome. The participants in intervention arm
will be received the username and password to use the
My Healthy Heart Profile and log-in to the interactive
section of website. Participants in intervention arm willbe encouraged to frequently log-in and visit their home-
page or ask questions at any time they wish. For the se-
curity and confidentiality, the users will receive personal
username and password. We will recommend the partic-
ipants to keep the password safe and avoid sharing it
with anyone. They will not able to change the password.
If any one forgets the password a new one will be sent
to his/her e-mails address.
My healthy heart profile
My Healthy Heart Profile is an interactive web-based
program designed for reducing metabolic syndrome.
The program is developed according to the ‘feedback
and monitoring’ as a behavior change technique [74]. It
is designed to send feedback to each participant accord-
ing to his/her metabolic syndrome indicators. In fact the
participants will receive text-based messages and graphic
feedbacks immediately after compellation of each records
of risk factors.
My Healthy Heart Profile is structured in six parts and
includes:
1. Personal home page: on the main page educational
materials will be uploaded every 2 weeks. The titles
are: Do you know your cholesterol level?, Control
your high blood pressure, Are you at risk for heart
disease, Do you need to lose weight?, Protect your
heart against diabetes, Physical activity and your
heart, and Lowering blood pressure. Users can
download and read all educational materials or save
and print to read it at convenient time.
2. Personal information includes name, age, gender,
weight, height, telephone number, and e-mail
address.
3. Inbox as an interactive section in the profile for
personal questions. Participants in intervention arm
can send personal questions and receive answers.
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participants’ inbox provided by a dietitian. The
calorie restricted diet will be based on each
participant’s calorie requirement according to his/
her ideal body weight (IBW) and corrected body
weight (CBW) with less than 30% of calories derived
from fat, in accordance with the National Heart,
Lung, and Blood Institute guidelines [75]. IBW will
be calculated with Hamwi equation [76]. CBW is
defined as ((IBW + 25% (actual body weight –
IBW)). We will request from intervention group to
adhere the dieting program.
4. A cardiovascular risk estimation tool for 10-years
(based on the Persian online version of Framingham
Risk Score-FSR). The FSR considers six cardiovascular
risk factors, including age (over than 20), gender
(male and female), total cholesterol (TC), HDL-
cholesterol, systolic blood pressure, and smoking
habits. This section is an interactive tool for users
to calculate the heart attack risk score in every
log-in and obtain feedback via the text by the three
traffic lights that are illustrated for three levels of
risks (high, moderate and low risk). If the estimation
of risk was over 20%, red light will bright and for
risk between 10 to 20% and less than 10% orange
and green light will turn on respectively. Users will
receive an explanation regarding their score and will
be guided to educational materials on the personal
homepage.
5. Anthropometric and clinical measures: in this
section user will record periodic measurements of
weight, waist circumference, BMI and blood pressure,
Total cholesterol, LDL-cholesterol, HDL-cholesterol,
triglycerides, and Fasting blood glucose. These
measurements will be displayed in a simple graph with
three warning color (red = needs attention, orange =
close to risk and green = good) for each recording.
The risk factors will draw at the sequence diagram
automatically and will show level of risks for individual
separately.
6. The questionnaires: users will complete a set of
study questionnaires.
Control
We will use a waiting list as the control group. In fact all
registrants will be exposed to the intervention but those
who register late will be kept in waiting list and as indi-
cated with be treated as control group for the study.
Thus, participants who will be assigned to this group
will receive an e-mail message every 3 weeks to keep
them involved in the study during the intervention
period but they will not have access to the My Healthy
Heart Profile and they will not know that they are con-
trol group. The e-mail messages will contain generalinformation about metabolic syndrome and healthy nutri-
tion and benefits of fruit and vegetable intakes, physical
activity and body weight loss. However, one should notice
that such a control group in essence is an intervention
group and not a true control group.
Primary outcomes
The primary outcomes are feasibility, acceptability, usabil-
ity, and the change in metabolic syndrome components.
Measures for assessing feasibility will include: the propor-
tion of participants who respond to log-in to My Healthy
Heart Profile for the first time, and response rate to postal
follow-up for clinical assessments and complete the study
questionnaires [77]. Acceptability will be explored by the
number of sign-in to the My Healthy Heart Profile during
intervention. Usability of the intervention will be accessed
by the educational materials downloads and using of web-
site components by participants. The change in metabolic
syndrome components will be assessed by calculating
changes in the following measures: waist circumferences,
weight, blood pressure, triglycerides, HDL-cholesterol,
and fasting blood glucose. Waist circumference will be
measured in horizontal plane, midway between the lowest
rib and the iliac crest with a measuring tape in centimeter
[6]. The weight of individual dressed in light clothing
without shoes will be measured at each time using a cali-
brated scale (Seca model 8811021658). Blood pressure will
be measured with mercury sphygmomanometer twice in
the same arm after the individual seated at rest 10–15
min. The systolic and diastolic measurement represents
the mean of two readings. Blood sampling will be collected
for measurements of total cholesterol, triglycerides, LDL-
cholesterol, HDL-cholesterol, and fasting blood glucose
for all participants. Overnight fasting for 12–14 h is
needed before blood sampling. Venous blood samples
(5 ml) will be collected. Body Mass Index (BMI) will be
measured by individual’s weight divided by the square
of the height [78].
Secondary outcomes
Secondary outcomes will include assessments of the
followings:
a. Health-related quality of life (HRQOL) using the
SF-36 (Iranian version). The SF-36 is a very popular
measure of health related quality of life among the
general population. The psychometric properties of
the Iranian version of the questionnaire are well
documented [79],
b. Physical activity using the International Physical
Activity Questionnaire at last 7 days (IPAQ) [80], a
well-validated questionnaire in Iran [81,82];
c. Food frequency using the validated Iranian version
of Food Frequency Questionnaire (FFQ) [83], and
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of 12-item General Health Questionnaire
(GHQ-12) [84].
Measurements will be made at baseline (T0), three (T1)
and six (T2) months follow-up. Food frequency question-
naire will be completed only on T0 and T2.
Sample size
The sample size was calculated based on one standard
deviation decrease (2.5) [85] in waist circumference as
one of the most important components of MS [86]. As
such a study with a power of 90% at 5% significance
level would need 60 participants in each arm. Giving
that there might be an attrition risk, 80 participants per
each group were sought.
Attrition prevention
In order to prevent attrition and encourage people to
take part in the study we will use five strategies appro-
priate to participants. Firstly, free blood testing will be
carried out for all participants at all three assessment
times. Secondly, the test results will send through e-mail
within 24 hours. We will request from users to log-in
the personal profile and record the new values. Thirdly,
e-mail reminders will send to users when they are in-
active for 2 weeks. Fourthly, in order to keep up to date
and enhance the website visiting, the new information
will be placed on the site monthly. Finally, all recruit-
ment processes will be online.
Statistical analysis
The characteristics of participants will be summarize as
proportions or means with standard deviations. To test
the study hypotheses t-tests for independent samples
will be performed. Comparisons of proportions will be
carried out using the Pearson’s chi-square test without
continuity correction. For all parameters 95% confidence
intervals will be defined. Two-sided p values of less than
0.05 will be regarded as statistical significant. All analyses
will be performed with the SPSS software version 18. Be-
tween group differences will be evaluated by intent-to-
treat analysis using the Generalized Linear Mixed Models
(GLMM).
Ethics
The ethics committee of the Tehran University of Medical
Sciences approved the study protocol. Written informed
consent is obtained from all participants.
Discussion
The Internet is promising medium to offer lifestyle inter-
ventions [87]. Perhaps this study will help in refining the
intervention for future research and practice. The resultsfrom this study, if successful, might help Iranians in sev-
eral ways. In the first instance it will help to set up simi-
lar interventions. Secondly it will help to reach target
populations as quickly as possible.
The study by Bosak et al. showed that web-based
intervention to increase physical activity in people with
metabolic syndrome appears feasible [22]. Recent evidence
support that lifestyle interventions including physical
activity and low-calorie diet might lead to at least 10%
weight loss [88].
Various studies showed a positive association between
log-in frequency and weight loss [44]. This approach may
also be more persuasive and motivational, with the ability
to promote rapid changes in participant’s behavior, but
remains to be tested.
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